You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells

Article metrics

Article menu

Download PDFPDF

Short Report
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells

 

Online download statistics by month:

Online download statistics by month: December 2019 to February 2026

AbstractFullPdf
Dec 2019550
Jan 2020880
Feb 202029291
Mar 202032325
Apr 2020505014
May 202044448
Jun 202019198
Jul 202026267
Aug 202029296
Sep 202042429
Oct 2020474712
Nov 202026264
Dec 2020292916
Jan 2021393930
Feb 2021323213
Mar 2021404037
Apr 2021484828
May 2021272713
Jun 2021333324
Jul 2021414116
Aug 2021202013
Sep 2021262628
Oct 2021343439
Nov 2021363721
Dec 2021454838
Jan 2022434826
Feb 2022262722
Mar 2022333723
Apr 2022333421
May 2022657034
Jun 2022444515
Jul 2022394114
Aug 2022444411
Sep 2022949516
Oct 2022394118
Nov 2022384026
Dec 2022313113
Jan 2023383813
Feb 2023454612
Mar 2023464615
Apr 2023373820
May 2023404120
Jun 2023343411
Jul 2023343414
Aug 2023343511
Sep 2023636411
Oct 202311111218
Nov 202324524515
Dec 2023454514
Jan 2024303122
Feb 2024545414
Mar 2024525227
Apr 2024434414
May 2024383817
Jun 2024313424
Jul 2024505114
Aug 2024242461
Sep 2024464611
Oct 2024495323
Nov 2024616214
Dec 2024929625
Jan 2025525662
Feb 2025404036
Mar 2025474738
Apr 2025737325
May 2025626231
Jun 2025373817
Sep 2025110
Feb 2026110
Total299130451278